Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(10%)
Results Posted
50%(3 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_1
1
10%
Ph phase_2
5
50%
Ph phase_4
2
20%
Ph early_phase_1
1
10%

Phase Distribution

2

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
5(50.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 11 (10.0%)
Phase 25 (50.0%)
Phase 42 (20.0%)
N/A1 (10.0%)

Trials by Status

recruiting110%
completed660%
terminated110%
unknown220%

Recent Activity

1 active trials
Showing 5 of 10
completedphase_2

Memory Improvement Through Nicotine Dosing (MIND) Study

NCT02720445
recruitingphase_4

PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.

NCT07095205
terminatedphase_2

Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy

NCT04468230
unknownearly_phase_1

Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia

NCT05301660
completedphase_4

UW-CTRI Triple Medication Smoking Cessation Study

NCT02681510
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT02720445Phase 2

Memory Improvement Through Nicotine Dosing (MIND) Study

Completed
NCT07095205Phase 4

PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.

Recruiting
NCT04468230Phase 2

Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy

Terminated
NCT05301660Early Phase 1

Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia

Unknown
NCT02681510Phase 4

UW-CTRI Triple Medication Smoking Cessation Study

Completed
NCT00124683Phase 2

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1

Completed
NCT01145001Not Applicable

Enhancing a High School Based Smoking Cessation Program

Completed
NCT01560754Phase 2

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease

Unknown
NCT01655082Phase 2

Nicotine Patch Safety Study

Completed
NCT00833404Phase 1

Smoking Cessation and Sexual Health in Men

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10